RxDoctor Payments Data

Mihir Joshi, MD

Pain Medicine · Minneapolis, MNNPI 1760844179

Payments from drug & device makers

What this record shows

17 manufacturers reported payments, led by Biotronik NRO, Inc. at 28.5% of the total.

$7,313in general payments, 2019–2025

Across 101 payments — averaging $72.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotronik NRO, Inc.$2K
  • Medtronic$2K
  • Boston Scientific$1K
  • Nevro Corp.$762
  • Abbott$527
  • Biodelivery Sciences International, Inc.$188
  • plus $436 from 11 others

What the payments were for

  • Travel & lodging$2,97241%
  • Food & beverage$4,34159%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,313 in reported general payments places this provider in the 75th percentile of 88 pain medicine providers in Minnesota.

See all pain medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$71,611
Medicare patients
169
Services billed
1,773

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin30$273

Paid to pharmacies, not to this prescriber.

Other pain medicine in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →